Disordered hemostasis in extrahepatic portal hypertension

Simon C. Robson, Delawir Kahn, J. Kruskal, Arthur R. Bird, Ralph E. Kirsch – 1 October 1993 – To assess the contribution of naturally occurring portal‐systemic shunts to the coagulopathy of patients with liver disease, we studied laboratory parameters of hemostasis in 20 adult patients with extrahepatic portal hypertension, secondary to portal vein thrombosis, that had resulted in variceal bleeding. All extrahepatic portal hypertension patients had normal liver function and histological appearance.

Regulation of iron metabolism in HepG2 cells: A possible role for cytokines in the hepatic deposition of iron

Michiaki Hirayama, Yutaka Kohgo, Hitoshi Kondo, Naoaki Shintani, Koshi Fujikawa, Katsunori Sasaki, Junji Kato, Yoshiro Nhtsu – 1 October 1993 – In chronic inflammation it is reported that serum iron is depleted and hepatic iron is increased because of reticuloendothelial system iron blockade.

Genetic predispositions for the immunological features of chronic active hepatitis

Albert J. Czaja, Herschel A. Carpenter, Paula J. Santrach, S. Breanndan Moore – 1 October 1993 – To assess the frequency and genetic predispositions of concurrent immunological diseases and immunoserological markers in autoimmune hepatitis and chronic viral hepatitis, we assessed 185 patients prospectively, including 122 patients with autoimmune hepatitis and 63 patients with viral disease. Human leukocyte antigens were determined in all patients.

Relationship between genomic DNA ploidy and parameters of liver damage during necrosis and regeneration induced by thioacetamide

Carmen Díez‐Fernández, Lisardo Boscá, Lourdes Fernández‐Simón, Alberto Alvarez, María Cascales – 1 October 1993 – Thioacetamide proved to be a potent necrogenic agent when a single dose of 6.6 mmol/kg was administered intraperitoneally to rats. Its necrogenic ability was assessed on the basis of morphological and biochemical changes. The injury of centrilobular hepatocytes showed a peak of cell death 24 hr after thioacetamide administration; it was followed immediately by the regenerative response.

Quantitative detection of hemoglobin saturation in the liver with near‐infrared spectroscopy

Toshiyuki Kitai, Akira Tanaka, Atsuo Tokuka, Koichi Tanaka, Yoshio Yamaoka, Kazue Ozawa, Konomu Hirao – 1 October 1993 – To quantify the changes in oxygen saturation of hemoglobin in the liver in hypoxia and liver transplantation, we applied a novel method using near‐infrared spectroscopy. Instead of the conventional two‐wavelength method, we obtained near‐infrared data from a wide spectral range of 700 nm to 1,000 nm with continuous‐wave spectroscopy.

Centrilobular distribution of acetaldehyde and collagen in the ethanol‐fed micropig

Charles H. Halsted, Jesús Villanueva, Carol J. Chandler, Boris Ruebner, Robert J. Munn, Seppo Parkkila, Onni Niemelä – 1 October 1993 – We established a new animal model of alcoholic liver disease in the micropig, a species that consumes ethanol voluntarily in the diet. Ten micropigs were pair‐fed diets containing 40% of calories as ethanol or cornstarch with identical amounts of fat, protein and micronutrients for 12 mo. Liver histopathology in the ethanol‐fed pigs included steatonecrosis in all five and interstitial and perivenous fibrosis in three.

Five‐year follow‐up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma‐derived vaccine in children: Immunogenicity and anamnestic responses

Ching‐Lung Lai, Benjamin Chun‐Yu Wong, Eng‐Kiong Yeoh, Wai‐Ling Lim, Wai‐Kwan Chang, Hsiang‐Ju Lin – 1 October 1993 – In a prospective randomized trial, 318 children aged between 3 mo and 11 yr who were negative for all hepatitis B markers were randomized to receive two 5‐μg doses of hepatitis B recombinant DNA yeast vaccine at 0 and 1 mo (group 1), three 5‐μg doses of hepatitis B recombinant DNA yeast vaccine at 0, 1 and 6 mo (group 2) or three 10‐μg doses of plasma‐derived hepatitis B vaccine (group 3).

Subscribe to